are glp 1 bad for you GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron Weight Loss and Obesity Just how safe are GLP-1
Description
No animals were excluded from analysis
Weight-loss drugs are booming in these US states with nearly 25% on GLP-1 meds in one obesity hot spot See more of our coverage in your search results
Bain, J.F.E
And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management
As competition intensifies, differentiation becomes more central to positioning
Best for self-pay users Treatments: injectable | Membership fee: none | Medication costs: $79+ to $299+/mo
